IPF
Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive fibrosing interstitial pneumonia of unknown cause, and the most common form of idiopathic interstitial pneumonia. It is characterized histologically by usual interstitial pneumonia (UIP) and radiographically by subpleural and basilar predominant fibrosis.
Epidemiology and risk factors: IPF typically presents in adults aged 60 to 70, with a male predominance
Pathophysiology: The disease is thought to result from repeated injury to alveolar epithelium in genetically susceptible
Clinical features: Patients commonly experience gradually worsening dyspnea on exertion and a dry cough. On examination,
Diagnosis: IPF is a diagnosis of exclusion, requiring careful assessment to rule out other causes of interstitial
Treatment and prognosis: There is no cure. Antifibrotic therapies, pirfenidone and nintedanib, slow disease progression. Supportive